Literature DB >> 2985744

Interactions between naloxone and GABA in the control of locomotor activity in the rat.

A Agmo, C Tarasco.   

Abstract

It was found that naloxone causes a small but significant reduction of motility. The GABAB agonist baclofen and the GABA transaminase inhibitor gamma-acetylenic GABA (GAG) also reduced locomotor activity. When a subeffective dose of baclofen was combined with naloxone 0.8 or 3.2 mg/kg, baclofen significantly inhibited motility beyond the inhibition caused by naloxone + saline. GAG, in a dose of 12.5 mg/kg, was also potentiated by naloxone, 3.2 mg/kg. The locomotion reducing effects of naloxone could be blocked by either picrotoxin or bicuculline. It is concluded that GABAergic mechanisms participate in the inhibition of locomotor activity provoked by naloxone. The possibility that this drug disinhibits GABAergic neurons is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985744     DOI: 10.1007/bf01251908

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  34 in total

1.  Opiate receptor agonists as modulators of gamma-aminobutyric acid turnover in the nucleus caudatus, globus pallidus and substantia nigra of the rat.

Authors:  F Moroni; D L Cheney; E Peralta; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

2.  The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo.

Authors:  M J Jung; B Lippert; B W Metcalf; P J Schechter; P Böhlen; A Sjoerdsma
Journal:  J Neurochem       Date:  1977-04       Impact factor: 5.372

3.  Effect of elevated brain GABA concentrations on the actions of bicuculline and picrotoxin in mice.

Authors:  P J Schechter; Y Tranier
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

Review 4.  Biochemical pharmacology of GABAergic agonists.

Authors:  S J Enna; A Maggi
Journal:  Life Sci       Date:  1979-05-07       Impact factor: 5.037

5.  Central effects of beta-(para-chlorophenyl)-gamma-aminobutyric acid.

Authors:  D R Curtis; C J Game; G A Johnston; R M McCulloch
Journal:  Brain Res       Date:  1974-04-26       Impact factor: 3.252

6.  Stimulant effects of enkephalin microinjection into the dopaminergic A10 area.

Authors:  C L Broekkamp; A G Phillips; A R Cools
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

7.  Electrophysiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. I. Effects on pyramidal cell activity.

Authors:  T Dunwiddie; A Mueller; M Palmer; J Stewart; B Hoffer
Journal:  Brain Res       Date:  1980-02-24       Impact factor: 3.252

8.  Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system.

Authors:  S R Zukin; A B Young; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

9.  Electrophysiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. II. Effects on interneuron excitability.

Authors:  H K Lee; T Dunwiddie; B Hoffer
Journal:  Brain Res       Date:  1980-02-24       Impact factor: 3.252

10.  Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies.

Authors:  R Dingledine; L L Iversen; E Breuker
Journal:  Eur J Pharmacol       Date:  1978-01-01       Impact factor: 4.432

View more
  2 in total

1.  Interactions between dopamine and GABA in the control of ambulatory activity.

Authors:  A Agmo; C Belzung; M Giordano
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  The GABAB receptor positive allosteric modulator ASP8062 reduces operant alcohol self-administration in male and female Sprague Dawley rats.

Authors:  Colin N Haile; Benjamin A Carper; Tracy L Nolen; Therese A Kosten
Journal:  Psychopharmacology (Berl)       Date:  2021-07-06       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.